6D Tape is unique, patented and active therapeutical tape which works in six directions. It features handles and is skin-friendly, making it well suited for lymphatic therapy, physical therapy, scar treatment and active self-care.
The unique 6D handles allow manipulation that stimulates lymph flow, blood circulation, fasciae, scar tissue, muscles and joints. Treatment with 6D Tape will improve recovery from injury, ease joint and muscle pain, reduce nerve compression and swelling, and help with constricting scar tissue.
6D Tape has many therapeutic uses. 6D Tape is effective for treating back, neck and muscle pain, as well as swelling and joints. Manipulating the tape with the handles alleviates pain and reduces swelling by activating the body’s internal cleanup and healing mechanisms. The tape is also suited for treating surgical and traumatic scar tissue and swelling. For example, the tape is excellent at treating repetitive strain injuries, including golfer’s, mouse and tennis elbow, and constricting connective tissue (fascia).
6D Tape works well with patients having Lymphedema, which is a painful chronic condition that causes swelling of limbs and disabilities affecting more than 250 million people worldwide. It has considerable public health significance, characterized by a continuous need for medical treatment, many comorbidities and detrimental effect on patients’ social life and career. It is particularly common among breast cancer survivors with a prevalence of about 40%. The number of lymphedema cases is rising as the number of cancer survivors increases with more effective treatments. The life quality of these people keeps declining dramatically as there are no solutions to manage this condition effectively and live a normal life at the same time.
6D Tape Oy is developing an automated therapy tape system 6D Tape Pro designed for efficient self-care to alleviate lymphedema, as well as pain, scars, and swelling after surgeries and injuries. The tape can be conveniently worn under clothes without interrupting any daily activities. The automated pulsation provides a gentle pressure treatment in planned and natural lymph flow-mimicking intervals. This enables lymphedema patient’s body to function and drain lymph similar to normal body preventing edema. The solution will reduce overall treatment costs and burden on health care systems.
Our patent-pending solutions are huge steps forward from any other treatment option available, enabling a lucrative positioning in a €7 billion market. The funding we are seeking is instrumental to take on the high-impact project closing the gap from technology prototype to a clinically validated product suited for mass market. Moreover, the new equity enables to secure enough operational capacity for a successful market launch.